Consistent with our finding, a study assayed 270 proteins in the CSF and plasma of Swedish subjects (BioFINDER cohort) using the PEA platform and reported alterations in plasma levels of HAGH and TIMP4, and the CSF levels of CHIT1, TNFRSF14 in AD patients [29]. Here, TIMP4 is linked to Alzheimer disease.